A breast cancer diagnosis can lead to significant anxiety, and for many survivors, this anxiety continues well beyond the end of treatment. While standard anxiety therapies are helpful for some, these therapies often fall short for breast cancer survivors due to an individual's unique experience-particularly changes in how survivors perceive and relate to the body, a process known as interoception. The study will evaluate the feasibility and acceptability of a novel interoceptive training approach called ADIE Therapy. ADIE Therapy trains participants to better recognise bodily signals, and has shown promising results in reducing anxiety in non-cancer populations. The aim of the study is to assess the acceptability and feasibility of ADIE Therapy for breast cancer survivors.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acceptability of the Intervention - Theoretical Framework of Acceptability (TFA) Questionnaire
Timeframe: Post-Treatment (Week 7)
Feasibility and Acceptability of the Intervention - Qualitative Interview
Timeframe: Post-Treatment (Week 7)
Acceptability of the Intervention - Net Promoter Score
Timeframe: Post-Treatment (Week 7)
Feasibility of the Study - Participant Retention
Timeframe: Baseline through Post-Treatment (Week 7)
Feasibility of the Study - Session Adherence
Timeframe: Baseline through Post-Treatment (Week 7)